Cargando…

Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions

SIMPLE SUMMARY: Tumor mutational burden (TMB) represents the number of mutations per megabase (muts/Mb) harbored by tumor cells in a given neoplasm, and can be determined with next-generation sequencing. High values are an indicator of potential response to immunotherapy. With this systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawlor, Rita T., Mattiolo, Paola, Mafficini, Andrea, Hong, Seung-Mo, Piredda, Maria L., Taormina, Sergio V., Malleo, Giuseppe, Marchegiani, Giovanni, Pea, Antonio, Salvia, Roberto, Kryklyva, Valentyna, Shin, Jae Il, Brosens, Lodewijk A., Milella, Michele, Scarpa, Aldo, Luchini, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269341/ https://www.ncbi.nlm.nih.gov/pubmed/34206554 http://dx.doi.org/10.3390/cancers13133119

Ejemplares similares

“Pure” hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms
por: Mattiolo, Paola, et al.
Publicado: (2022)

Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
por: Luchini, Claudio, et al.
Publicado: (2021)

Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma
por: Mafficini, Andrea, et al.
Publicado: (2022)

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
por: Luchini, Claudio, et al.
Publicado: (2020)

Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells
por: Mattiolo, Paola, et al.
Publicado: (2020)

Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
por: Luchini, Claudio, et al.
Publicado: (2021)

Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants
por: Mafficini, Andrea, et al.
Publicado: (2022)

CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype
por: Mattiolo, Paola, et al.
Publicado: (2020)

Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling
por: Mafficini, Andrea, et al.
Publicado: (2021)

Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring
por: Luchini, Claudio, et al.
Publicado: (2022)

Mismatch repair deficiency in early‐onset duodenal, ampullary, and pancreatic carcinomas is a strong indicator for a hereditary defect
por: Kryklyva, Valentyna, et al.
Publicado: (2021)

Artificial intelligence in oncology: current applications and future perspectives
por: Luchini, Claudio, et al.
Publicado: (2021)

CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Maggino, Laura, et al.
Publicado: (2022)

Prognostic Role of High-Grade Tumor Budding in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis with a Focus on Epithelial to Mesenchymal Transition
por: Lawlor, Rita T., et al.
Publicado: (2019)

Ampulla of Vater carcinoma: Molecular landscape and clinical implications
por: Pea, Antonio, et al.
Publicado: (2018)

Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma
por: Riva, Giulio, et al.
Publicado: (2018)

Characterization and digital spatial deconvolution of the immune microenvironment of intraductal oncocytic papillary neoplasms (IOPN) of the pancreas
por: Pea, Antonio, et al.
Publicado: (2023)

Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
por: Young, Kate, et al.
Publicado: (2021)

Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine
por: Luchini, Claudio, et al.
Publicado: (2019)

Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

Total pancreatectomy and pancreatic fistula: friend or foe?
por: Salvia, Roberto, et al.
Publicado: (2021)

Whole exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1
por: Noë, Michaël, et al.
Publicado: (2018)

Neuroendocrine neoplasms of the biliary tree, liver and pancreas: a pathological approach
por: Luchini, Claudio, et al.
Publicado: (2021)

Pancreatic acinar cell carcinoma is associated with BRCA2 germline mutations: a case report and literature review
por: Kryklyva, Valentyna, et al.
Publicado: (2019)

Recurrent oligodendroglioma with changed 1p/19q status
por: Barresi, Valeria, et al.
Publicado: (2022)

Intraductal tubulopapillary neoplasm (ITPN) of the pancreas: a distinct entity among pancreatic tumors
por: Paolino, Gaetano, et al.
Publicado: (2022)

Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation: A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival
por: Kryklyva, Valentyna, et al.
Publicado: (2020)

Non-coding regulatory variations: the dark matter of pancreatic cancer genomics
por: Scarpa, Aldo, et al.
Publicado: (2018)

Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium
por: Mafficini, Andrea, et al.
Publicado: (2018)

Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Mafficini, Andrea, et al.
Publicado: (2019)

Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol
por: Malleo, Giuseppe, et al.
Publicado: (2022)

Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas
por: Amato, Eliana, et al.
Publicado: (2018)

CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas
por: Lawlor, Rita T., et al.
Publicado: (2018)

Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas
por: Amato, Eliana, et al.
Publicado: (2014)

Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis
por: Casolino, Raffaella, et al.
Publicado: (2021)

RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
por: Amato, Eliana, et al.
Publicado: (2016)

Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary
por: Luchini, Claudio, et al.
Publicado: (2018)

BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing
por: Mafficini, Andrea, et al.
Publicado: (2016)

Pancreatic surgery during COVID-19 pandemic: major activity disruption of a third-level referral center during 2020
por: Marchegiani, Giovanni, et al.
Publicado: (2021)

DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples
por: Simbolo, Michele, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1sh8468est47t0325tcat37c0u